Alena van Bömmel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alena van Bömmel has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Steve Hoffmann
Computational Biology Group, Leibniz Institute on Aging—Fritz Lipmann Institute (FLI), Jena, Germany
4 shared publications Konstantin Riege
Hoffmann Lab, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany
3 shared publications- Robert Schwarz
Computational Biology Group (Hoffmann Lab), Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Beutenbergstraße 11, Jena, 07745, Germany
3 shared publications - Alexander Loewer
Department of Biology, Technical University of Darmstadt, Darmstadt, Germany
2 shared publications - Elina Wiechens
Computational Biology Group, Leibniz Institute on Aging—Fritz Lipmann Institute (FLI) , Beutenbergstraße 11 , 07745 Jena
2 shared publications Ivonne Görlich
Core Facility Next Generation Sequencing, Leibniz Institute on Aging–Fritz Lipmann Institute (FLI), Jena, Germany
2 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (13)
Enhancing the performance and interpretability of epigenetic clocks
Epigenetic clocks based on DNA methylation (DNAm) accurately predict age, but their biological underpinnings remain unclear. One primary mechanism by which DNAm might influence gene regulation is by modulating transcription factor binding activity. This study investigates the regulatory potential of predictive CpGs in established epigenetic clocks. Our analysis reveals that generally most CpGs used by epigenetic clocks do not overlap known transcription factor binding sites (TFBS), indicating that clock accuracy is not primarily driven by changes in TF binding dynamics. However, analysis of CpGs within TFBSs identifies key transcription factors potentially involved in aging, including ZBED1, NFE2, and CEBPB, which are enriched for age-associated CpGs, while RELA, IKZF1, and STAT3 significantly protected against methylation changes. Leveraging TFBS-associated and age-correlated CpGs, combined with noise-stabilizing feature engineering steps, we developed an alternative TFMethyl Clock model that provides competitive predictions of chronological age. Age-predictive CpGs selected by our model enrich for target genes involved in interleukin-1β production and fatty-acid metabolism, while being enriched at TFBSs of NR2C2. Furthermore, approximately three-fourths of these target genes exhibit significant age-related changes, suggesting deeper insights into possible methylation-driven aging processes. Our findings demonstrate that incorporating regulatory information into epigenetic clocks may provide mechanistic insights into the aging process while improving the interpretability and predictive power.
- 3 July 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (13)
Open AccessEnhancing the performance and interpretability of epigenetic clocks
Epigenetic clocks based on DNA methylation (DNAm) accurately predict age, but their biological underpinnings remain unclear. One primary mechanism by which DNAm might influence gene regulation is by modulating transcription factor binding activity. This study investigates the regulatory potential of predictive CpGs in established epigenetic clocks. Our analysis reveals that generally most CpGs used by epigenetic clocks do not overlap known transcription factor binding sites (TFBS), indicating that clock accuracy is not primarily driven by changes in TF binding dynamics. However, analysis of CpGs within TFBSs identifies key transcription factors potentially involved in aging, including ZBED1, NFE2, and CEBPB, which are enriched for age-associated CpGs, while RELA, IKZF1, and STAT3 significantly protected against methylation changes. Leveraging TFBS-associated and age-correlated CpGs, combined with noise-stabilizing feature engineering steps, we developed an alternative TFMethyl Clock model that provides competitive predictions of chronological age. Age-predictive CpGs selected by our model enrich for target genes involved in interleukin-1β production and fatty-acid metabolism, while being enriched at TFBSs of NR2C2. Furthermore, approximately three-fourths of these target genes exhibit significant age-related changes, suggesting deeper insights into possible methylation-driven aging processes. Our findings demonstrate that incorporating regulatory information into epigenetic clocks may provide mechanistic insights into the aging process while improving the interpretability and predictive power.
- Open Access
- 16 May 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (6)
Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study
Background: Circulating HBsAg, HBV RNA, and hepatitis B core-related antigen (HBcrAg) are potential biomarkers for the response to nucleos(t)ide analog (NA) treatment discontinuation in patients with chronic hepatitis B (CHB). We retrospectively investigated the long-term kinetics of HBsAg, HBV RNA, and HBcrAg in HBeAg-negative patients treated with NA for up to 14 years in a prospective cohort study. Methods: Ninety-six patients (mean age 65 y, 77% male, 52% with cirrhosis, all HBV genotype D) who were undergoing first (n=33, group A) or second-line (n=63, group B) treatment with tenofovir disoproxil fumarate were included. HBV biomarkers collected during tenofovir disoproxil fumarate treatment were measured in 384 serum samples stored at −20 °C. The combined biomarker endpoints associated with functional cure following NA discontinuation included HBsAg 10 copies/mL) and 80% (mean 4.3±1.9 [2–8.9] log10 U/mL), respectively, of the patients in group A. In groups A and B, the percentages of patients with detectable HBV RNA levels decreased to 53% and 34%, respectively, during years 8–10 of NA treatment, and to 29% in group B during years 11–14 to 29%. HBcrAg could be quantified in 2% of patients in group B NA treatment years 8–10. Combined biomarker endpoints were met at baseline and at years 1–4, 5–7, 8–10, and 11–14 of treatment by 3.3%, 12% and 14%, 13% and 38%, 26% and 29%, and 41% of patients, respectively. Conclusions: HBV biomarker endpoints are associated with functional cure after the discontinuation of NA increase during long-term NA treatment.
- 16 May 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (6)
Open AccessDynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study
Background: Circulating HBsAg, HBV RNA, and hepatitis B core-related antigen (HBcrAg) are potential biomarkers for the response to nucleos(t)ide analog (NA) treatment discontinuation in patients with chronic hepatitis B (CHB). We retrospectively investigated the long-term kinetics of HBsAg, HBV RNA, and HBcrAg in HBeAg-negative patients treated with NA for up to 14 years in a prospective cohort study. Methods: Ninety-six patients (mean age 65 y, 77% male, 52% with cirrhosis, all HBV genotype D) who were undergoing first (n=33, group A) or second-line (n=63, group B) treatment with tenofovir disoproxil fumarate were included. HBV biomarkers collected during tenofovir disoproxil fumarate treatment were measured in 384 serum samples stored at −20 °C. The combined biomarker endpoints associated with functional cure following NA discontinuation included HBsAg 10 copies/mL) and 80% (mean 4.3±1.9 [2–8.9] log10 U/mL), respectively, of the patients in group A. In groups A and B, the percentages of patients with detectable HBV RNA levels decreased to 53% and 34%, respectively, during years 8–10 of NA treatment, and to 29% in group B during years 11–14 to 29%. HBcrAg could be quantified in 2% of patients in group B NA treatment years 8–10. Combined biomarker endpoints were met at baseline and at years 1–4, 5–7, 8–10, and 11–14 of treatment by 3.3%, 12% and 14%, 13% and 38%, 26% and 29%, and 41% of patients, respectively. Conclusions: HBV biomarker endpoints are associated with functional cure after the discontinuation of NA increase during long-term NA treatment.
- Top Cited PapersOpen Access
- 28 February 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (3) , 840-848
Rapid brain tumor classification from sparse epigenomic data
Although the intraoperative molecular diagnosis of the approximately 100 known brain tumor entities described to date has been a goal of neuropathology for the past decade, achieving this within a clinically relevant timeframe of under 1 h after biopsy collection remains elusive. Advances in third-generation sequencing have brought this goal closer, but established machine learning techniques rely on computationally intensive methods, making them impractical for live diagnostic workflows in clinical applications. Here we present MethyLYZR, a naive Bayesian framework enabling fully tractable, live classification of cancer epigenomes. For evaluation, we used nanopore sequencing to classify over 200 brain tumor samples, including 10 sequenced in a clinical setting next to the operating room, achieving highly accurate results within 15 min of sequencing. MethyLYZR can be run in parallel with an ongoing nanopore experiment with negligible computational overhead. Therefore, the only limiting factors for even faster time to results are DNA extraction time and the nanopore sequencer’s maximum parallel throughput. Although more evidence from prospective studies is needed, our study suggests the potential applicability of MethyLYZR for live molecular classification of nervous system malignancies using nanopore sequencing not only for the neurosurgical intraoperative use case but also for other oncologic indications and the classification of tumors from cell-free DNA in liquid biopsies.
- 28 February 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (3) , 840-848
Top Cited PapersOpen AccessRapid brain tumor classification from sparse epigenomic data
Although the intraoperative molecular diagnosis of the approximately 100 known brain tumor entities described to date has been a goal of neuropathology for the past decade, achieving this within a clinically relevant timeframe of under 1 h after biopsy collection remains elusive. Advances in third-generation sequencing have brought this goal closer, but established machine learning techniques rely on computationally intensive methods, making them impractical for live diagnostic workflows in clinical applications. Here we present MethyLYZR, a naive Bayesian framework enabling fully tractable, live classification of cancer epigenomes. For evaluation, we used nanopore sequencing to classify over 200 brain tumor samples, including 10 sequenced in a clinical setting next to the operating room, achieving highly accurate results within 15 min of sequencing. MethyLYZR can be run in parallel with an ongoing nanopore experiment with negligible computational overhead. Therefore, the only limiting factors for even faster time to results are DNA extraction time and the nanopore sequencer’s maximum parallel throughput. Although more evidence from prospective studies is needed, our study suggests the potential applicability of MethyLYZR for live molecular classification of nervous system malignancies using nanopore sequencing not only for the neurosurgical intraoperative use case but also for other oncologic indications and the classification of tumors from cell-free DNA in liquid biopsies.
- Open Access
- 6 January 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (1) , 206-217
Gene regulation by convergent promoters
Convergent transcription, that is, the collision of sense and antisense transcription, is ubiquitous in mammalian genomes and believed to diminish RNA expression. Recently, antisense transcription downstream of promoters was found to be surprisingly prevalent. However, functional characteristics of affected promoters are poorly investigated. Here we show that convergent transcription marks an unexpected positively co-regulated promoter constellation. By assessing transcriptional dynamic systems, we identified co-regulated constituent promoters connected through a distinct chromatin structure. Within these cis -regulatory domains, transcription factors can regulate both constituting promoters by binding to only one of them. Convergent promoters comprise about a quarter of all active transcript start sites and initiate 5′-overlapping antisense RNAs—an RNA class believed previously to be rare. Visualization of nascent RNA molecules reveals convergent cotranscription at these loci. Together, our results demonstrate that co-regulated convergent promoters substantially expand the cis -regulatory repertoire, reveal limitations of the transcription interference model and call for adjusting the promoter concept.
- 6 January 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (1) , 206-217
Open AccessGene regulation by convergent promoters
Convergent transcription, that is, the collision of sense and antisense transcription, is ubiquitous in mammalian genomes and believed to diminish RNA expression. Recently, antisense transcription downstream of promoters was found to be surprisingly prevalent. However, functional characteristics of affected promoters are poorly investigated. Here we show that convergent transcription marks an unexpected positively co-regulated promoter constellation. By assessing transcriptional dynamic systems, we identified co-regulated constituent promoters connected through a distinct chromatin structure. Within these cis -regulatory domains, transcription factors can regulate both constituting promoters by binding to only one of them. Convergent promoters comprise about a quarter of all active transcript start sites and initiate 5′-overlapping antisense RNAs—an RNA class believed previously to be rare. Visualization of nascent RNA molecules reveals convergent cotranscription at these loci. Together, our results demonstrate that co-regulated convergent promoters substantially expand the cis -regulatory repertoire, reveal limitations of the transcription interference model and call for adjusting the promoter concept.
- Open Access
- 9 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Nonlinear DNA methylation trajectories in aging male mice
Although DNA methylation data yields highly accurate age predictors, little is known about the dynamics of this quintessential epigenomic biomarker during lifespan. To narrow the gap, we investigate the methylation trajectories of male mouse colon at five different time points of aging. Our study indicates the existence of sudden hypermethylation events at specific stages of life. Precisely, we identify two epigenomic switches during early-to-midlife (3-9 months) and mid-to-late-life (15-24 months) transitions, separating the rodents’ life into three stages. These nonlinear methylation dynamics predominantly affect genes associated with the nervous system and enrich in bivalently marked chromatin regions. Based on groups of nonlinearly modified loci, we construct a clock-like classifier STageR (STage of aging estimatoR) that accurately predicts murine epigenetic stage. We demonstrate the universality of our clock in an independent mouse cohort and with publicly available datasets.
- 9 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessNonlinear DNA methylation trajectories in aging male mice
Although DNA methylation data yields highly accurate age predictors, little is known about the dynamics of this quintessential epigenomic biomarker during lifespan. To narrow the gap, we investigate the methylation trajectories of male mouse colon at five different time points of aging. Our study indicates the existence of sudden hypermethylation events at specific stages of life. Precisely, we identify two epigenomic switches during early-to-midlife (3-9 months) and mid-to-late-life (15-24 months) transitions, separating the rodents’ life into three stages. These nonlinear methylation dynamics predominantly affect genes associated with the nervous system and enrich in bivalently marked chromatin regions. Based on groups of nonlinearly modified loci, we construct a clock-like classifier STageR (STage of aging estimatoR) that accurately predicts murine epigenetic stage. We demonstrate the universality of our clock in an independent mouse cohort and with publicly available datasets.
- Open Access
- 16 October 2023
- Published by Springer Nature in Leukemia
- Vol. 37 (12) , 2522-2525
Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
- 16 October 2023
- Published by Springer Nature in Leukemia
- Vol. 37 (12) , 2522-2525
Open AccessRecurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
- Open Access
- 25 May 2023
- Published by Springer Nature in Research Square
Super-promoters: Cooperativity between juxtaposed promoters
The coordination of transcription through enhancers and promoters is a fundamental process that has a central role in development and disease 1–3. Convergent transcription, i.e., the collision of sense and antisense transcription, is ubiquitous in mammalian genomes 4–8 and believed to diminish RNA expression 9,10. Recently, antisense transcription downstream of promoters was found to be surprisingly prevalent 11–13. However, functional characteristics of promoters with convergent transcription are unknown. Here, we show that convergent transcription marks an unexpectedly cooperative promoter constellation we call super-promoters. By assessing transcriptional dynamic systems, we identified strongly cooperative constituent promoters that are connected through a distinct chromatin structure. Within these super-promoter constellations transcription factors can regulate both constituting promoters by binding to only one of them. Super-promoters comprise about a fourth of all active transcript starts and initiate 5’-overlapping antisense RNAs, an RNA class previously believed to be rare 4. Visualization of nascent RNA molecules provides evidence for convergent co-transcription at these loci. Our results demonstrate that super-promoters substantially expand the cis-regulatory repertoire and reveal limitations of the standing model of transcription interference. Together, our study revises the promoter architecture of many genes and calls for adjusting the promoter concept.
- 25 May 2023
- Published by Springer Nature in Research Square
Open AccessSuper-promoters: Cooperativity between juxtaposed promoters
The coordination of transcription through enhancers and promoters is a fundamental process that has a central role in development and disease 1–3. Convergent transcription, i.e., the collision of sense and antisense transcription, is ubiquitous in mammalian genomes 4–8 and believed to diminish RNA expression 9,10. Recently, antisense transcription downstream of promoters was found to be surprisingly prevalent 11–13. However, functional characteristics of promoters with convergent transcription are unknown. Here, we show that convergent transcription marks an unexpectedly cooperative promoter constellation we call super-promoters. By assessing transcriptional dynamic systems, we identified strongly cooperative constituent promoters that are connected through a distinct chromatin structure. Within these super-promoter constellations transcription factors can regulate both constituting promoters by binding to only one of them. Super-promoters comprise about a fourth of all active transcript starts and initiate 5’-overlapping antisense RNAs, an RNA class previously believed to be rare 4. Visualization of nascent RNA molecules provides evidence for convergent co-transcription at these loci. Our results demonstrate that super-promoters substantially expand the cis-regulatory repertoire and reveal limitations of the standing model of transcription interference. Together, our study revises the promoter architecture of many genes and calls for adjusting the promoter concept.
- Open Access
Assessing genome-wide dynamic changes in enhancer activity during early mESC differentiation by FAIRE-STARR-seq
Embryonic stem cells (ESCs) can differentiate into any given cell type and therefore represent a versatile model to study the link between gene regulation and differentiation. To quantitatively assess the dynamics of enhancer activity during the early stages of murine ESC differentiation, we analyzed accessible genomic regions using STARR-seq, a massively parallel reporter assay. This resulted in a genome-wide quantitative map of active mESC enhancers, in pluripotency and during the early stages of differentiation. We find that only a minority of accessible regions is active and that such regions are enriched near promoters, characterized by specific chromatin marks, enriched for distinct sequence motifs, and modeling shows that active regions can be predicted from sequence alone. Regions that change their activity upon retinoic acid-induced differentiation are more prevalent at distal intergenic regions when compared to constitutively active enhancers. Further, analysis of differentially active enhancers verified the contribution of individual TF motifs toward activity and inducibility as well as their role in regulating endogenous genes. Notably, the activity of retinoic acid receptor alpha (RARα) occupied regions can either increase or decrease upon the addition of its ligand, retinoic acid, with the direction of the change correlating with spacing and orientation of the RARα consensus motif and the co-occurrence of additional sequence motifs. Together, our genome-wide enhancer activity map elucidates features associated with enhancer activity levels, identifies regulatory regions disregarded by computational prediction tools, and provides a resource for future studies into regulatory elements in mESCs.
Open AccessAssessing genome-wide dynamic changes in enhancer activity during early mESC differentiation by FAIRE-STARR-seq
Embryonic stem cells (ESCs) can differentiate into any given cell type and therefore represent a versatile model to study the link between gene regulation and differentiation. To quantitatively assess the dynamics of enhancer activity during the early stages of murine ESC differentiation, we analyzed accessible genomic regions using STARR-seq, a massively parallel reporter assay. This resulted in a genome-wide quantitative map of active mESC enhancers, in pluripotency and during the early stages of differentiation. We find that only a minority of accessible regions is active and that such regions are enriched near promoters, characterized by specific chromatin marks, enriched for distinct sequence motifs, and modeling shows that active regions can be predicted from sequence alone. Regions that change their activity upon retinoic acid-induced differentiation are more prevalent at distal intergenic regions when compared to constitutively active enhancers. Further, analysis of differentially active enhancers verified the contribution of individual TF motifs toward activity and inducibility as well as their role in regulating endogenous genes. Notably, the activity of retinoic acid receptor alpha (RARα) occupied regions can either increase or decrease upon the addition of its ligand, retinoic acid, with the direction of the change correlating with spacing and orientation of the RARα consensus motif and the co-occurrence of additional sequence motifs. Together, our genome-wide enhancer activity map elucidates features associated with enhancer activity levels, identifies regulatory regions disregarded by computational prediction tools, and provides a resource for future studies into regulatory elements in mESCs.
- Open Access
- 24 August 2018
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 14 (8) , e1006372
coTRaCTE predicts co-occurring transcription factors within cell-type specific enhancers
Cell-type specific gene expression is regulated by the combinatorial action of transcription factors (TFs). In this study, we predict transcription factor (TF) combinations that cooperatively bind in a cell-type specific manner. We first divide DNase hypersensitive sites into cell-type specifically open vs. ubiquitously open sites in 64 cell types to describe possible cell-type specific enhancers. Based on the pattern contrast between these two groups of sequences we develop “co-occurring TF predictor on Cell-Type specific Enhancers” (coTRaCTE) - a novel statistical method to determine regulatory TF co-occurrences. Contrasting the co-binding of TF pairs between cell-type specific and ubiquitously open chromatin guarantees the high cell-type specificity of the predictions. coTRaCTE predicts more than 2000 co-occurring TF pairs in 64 cell types. The large majority (70%) of these TF pairs is highly cell-type specific and overlaps in TF pair co-occurrence are highly consistent among related cell types. Furthermore, independently validated co-occurring and directly interacting TFs are significantly enriched in our predictions. Focusing on the regulatory network derived from the predicted co-occurring TF pairs in embryonic stem cells (ESCs) we find that it consists of three subnetworks with distinct functions: maintenance of pluripotency governed by OCT4, SOX2 and NANOG, regulation of early development governed by KLF4, STAT3, ZIC3 and ZNF148 and general functions governed by MYC, TCF3 and YY1. In summary, coTRaCTE predicts highly cell-type specific co-occurring TFs which reveal new insights into transcriptional regulatory mechanisms. Differentiation of multicellular organisms into a variety of cell types with different morphology and function is the result of cell-type specific gene expression. The most important regulators of gene expression are transcription factors (TFs) binding to cis-regulatory sequences, such as enhancers or promoters. In particular, the combinatorial cooperativity of TFs is essential for defining the cell-type specificity. However, the experimental detection of cooperative TFs on a large scale is very difficult. Here, we develop a new strategy for predicting co-occurring TFs in a cell-type specific manner. We use a simple statistical test of TF co-binding between cell-type specific enhancers and globally active regulatory regions which assures the specificity and significance of predicted TF co-occurrences. Using chromatin accessibility data in 90 cell lines enables us to predict more than 2000 co-occurring TF pairs in 64 cell types. We confirm our predictions by multiple means, including comparison with large-scale experimental data. Based on our method, we obtain new insights into the cell-type specific TF cooperativity, and the complexity of transcriptional regulatory mechanisms.
- 24 August 2018
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 14 (8) , e1006372
Open AccesscoTRaCTE predicts co-occurring transcription factors within cell-type specific enhancers
Cell-type specific gene expression is regulated by the combinatorial action of transcription factors (TFs). In this study, we predict transcription factor (TF) combinations that cooperatively bind in a cell-type specific manner. We first divide DNase hypersensitive sites into cell-type specifically open vs. ubiquitously open sites in 64 cell types to describe possible cell-type specific enhancers. Based on the pattern contrast between these two groups of sequences we develop “co-occurring TF predictor on Cell-Type specific Enhancers” (coTRaCTE) - a novel statistical method to determine regulatory TF co-occurrences. Contrasting the co-binding of TF pairs between cell-type specific and ubiquitously open chromatin guarantees the high cell-type specificity of the predictions. coTRaCTE predicts more than 2000 co-occurring TF pairs in 64 cell types. The large majority (70%) of these TF pairs is highly cell-type specific and overlaps in TF pair co-occurrence are highly consistent among related cell types. Furthermore, independently validated co-occurring and directly interacting TFs are significantly enriched in our predictions. Focusing on the regulatory network derived from the predicted co-occurring TF pairs in embryonic stem cells (ESCs) we find that it consists of three subnetworks with distinct functions: maintenance of pluripotency governed by OCT4, SOX2 and NANOG, regulation of early development governed by KLF4, STAT3, ZIC3 and ZNF148 and general functions governed by MYC, TCF3 and YY1. In summary, coTRaCTE predicts highly cell-type specific co-occurring TFs which reveal new insights into transcriptional regulatory mechanisms. Differentiation of multicellular organisms into a variety of cell types with different morphology and function is the result of cell-type specific gene expression. The most important regulators of gene expression are transcription factors (TFs) binding to cis-regulatory sequences, such as enhancers or promoters. In particular, the combinatorial cooperativity of TFs is essential for defining the cell-type specificity. However, the experimental detection of cooperative TFs on a large scale is very difficult. Here, we develop a new strategy for predicting co-occurring TFs in a cell-type specific manner. We use a simple statistical test of TF co-binding between cell-type specific enhancers and globally active regulatory regions which assures the specificity and significance of predicted TF co-occurrences. Using chromatin accessibility data in 90 cell lines enables us to predict more than 2000 co-occurring TF pairs in 64 cell types. We confirm our predictions by multiple means, including comparison with large-scale experimental data. Based on our method, we obtain new insights into the cell-type specific TF cooperativity, and the complexity of transcriptional regulatory mechanisms.